|

Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA

RECRUITINGSponsored by The First Affiliated Hospital with Nanjing Medical University
Actively Recruiting
SponsorThe First Affiliated Hospital with Nanjing Medical University
Started2022-01-01
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study aims to further improve and expand the WB-MRI imaging evaluation cohort of axSpA patients to complete dynamic follow-up and condition assessment. Based on the WB-MRI features, the association of WB-MRI signs with disease activity, inflammation, and structural damage will be analyzed. At the same time, in-depth data mining was conducted and machine learning was used to construct a new axSpA disease activity assessment model based on WB-MRI data, and the accuracy and reliability of the model were clearly evaluated in the discovery cohort and validation cohort.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Include newly referred patients if:

The onset of symptoms (back pain/arthritis/enthesitis) \< 45 years

Undiagnosed disease with the following symptoms:

chronic back pain (duration of back pain more than 3 months) and/or peripheral arthritis (asymmetric arthritis/predominantly of the lower limbs) and/or enthesitis and/or dactylitis

Exclusion Criteria:

And diagnosed with non-radiographic or radiographic axial SpA

Conditions3

ArthritisSpondyloarthritis (SpA)Whole-body MRI (WBMRI)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.